TY  - GEN 
AU  - Lluch Gómez, J.
AU  - Núñez Álvarez, V.
AU  - de la Torre-Hita, C.
AU  - Bernal Gómez, Marco
AU  - Campini Bermejo, A.
AU  - Perdomo Zaldívar, E.
AU  - Rodríguez Pérez, L.
AU  - Calvete Candenas, J.
AU  - Martínez Bautista, M.J.
AU  - Benítez Rodríguez, E.
AU  - Baena Cañada, José Manuel
A4  - Medicina
PY  - 2023
SN  - 2045-2322
UR  - http://hdl.handle.net/10498/29626
AB  - Adjuvant trastuzumab in HER2+ breast cancer reduces recurrence and mortality, and has been the standard treatment since 2006. The objective was to analyze health outcomes in the real world. Observational, retrospective study of patients with HER2+...
LA  - eng
PB  - Springer
KW  - breast cancer
KW  - Adjuvant trastuzumab
KW  - Retrospective Studies
TI  - Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer
DO  - 10.1038/s41598-023-34429-9
ER  -